Does the media prefer DUOT or HCAT?

In the previous week, Duos Technologies Group had 2 more articles in the media than Health Catalyst. MarketBeat recorded 4 mentions for Duos Technologies Group and 2 mentions for Health Catalyst. Duos Technologies Group's average media sentiment score of 0.53 beat Health Catalyst's score of 0.47 indicating that Duos Technologies Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Duos Technologies Group 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Health Catalyst 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to HCAT or MTLS?

In the previous week, Health Catalyst and Health Catalyst both had 2 articles in the media. Materialise's average media sentiment score of 1.78 beat Health Catalyst's score of 0.47 indicating that Materialise is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health Catalyst 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Materialise 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has preferable valuation and earnings, TBRG or HCAT?

TruBridge has higher revenue and earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than TruBridge, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TruBridge $346.84M 1.13 $4.21M $0.20 130.35 Health Catalyst $302.48M 0.40 -$177.97M -$3.72 N/A

Does the media prefer TBRG or HCAT?

In the previous week, TruBridge had 3 more articles in the media than Health Catalyst. MarketBeat recorded 5 mentions for TruBridge and 2 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 0.47 beat TruBridge's score of -0.01 indicating that Health Catalyst is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TruBridge 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Health Catalyst 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation and earnings, XPER or HCAT?

Xperi has higher revenue and earnings than Health Catalyst. Xperi is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Xperi $448.11M 0.81 -$56.34M -$0.99 N/A Health Catalyst $302.48M 0.40 -$177.97M -$3.72 N/A

Is XPER or HCAT more profitable?

Xperi has a net margin of -10.22% compared to Health Catalyst's net margin of -87.69%. Xperi's return on equity of 1.09% beat Health Catalyst's return on equity. Company Net Margins Return on Equity Return on Assets Xperi -10.22% 1.09% 0.73% Health Catalyst -87.69% -3.52% -1.77%

Does the media favor XPER or HCAT?

In the previous week, Health Catalyst had 1 more articles in the media than Xperi. MarketBeat recorded 2 mentions for Health Catalyst and 1 mentions for Xperi. Health Catalyst's average media sentiment score of 0.47 beat Xperi's score of 0.46 indicating that Health Catalyst is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Xperi 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Health Catalyst 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to HCAT or SMWB?

In the previous week, Health Catalyst and Health Catalyst both had 2 articles in the media. Similarweb's average media sentiment score of 0.97 beat Health Catalyst's score of 0.47 indicating that Similarweb is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health Catalyst 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Similarweb 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Health Catalyst (HCAT) Competitors

$1.64 +0.04 (+2.50%)

Closing price 04:00 PM Eastern

Extended Trading

$1.60 -0.04 (-2.44%)

As of 06:28 PM Eastern

Compare

HCAT vs. DUOT, MTLS, TBRG, XPER, and SMWB

Should you buy Health Catalyst stock or one of its competitors? MarketBeat compares Health Catalyst with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Health Catalyst include Duos Technologies Group (DUOT), Materialise (MTLS), TruBridge (TBRG), Xperi (XPER), and Similarweb (SMWB). These companies are all part of the "computer software" industry.

How does Health Catalyst compare to Duos Technologies Group?

Duos Technologies Group (NASDAQ:DUOT) and Health Catalyst (NASDAQ:HCAT) are both small-cap computer software companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

Duos Technologies Group has a net margin of -45.36% compared to Health Catalyst's net margin of -87.69%. Health Catalyst's return on equity of -3.52% beat Duos Technologies Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Duos Technologies Group	-45.36%	-21.46%	-15.66%
Health Catalyst	-87.69%	-3.52%	-1.77%

Duos Technologies Group currently has a consensus price target of $17.00, suggesting a potential upside of 40.96%. Health Catalyst has a consensus price target of $2.77, suggesting a potential upside of 69.07%. Given Health Catalyst's stronger consensus rating and higher probable upside, analysts clearly believe Health Catalyst is more favorable than Duos Technologies Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Duos Technologies Group	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.23

Duos Technologies Group has higher earnings, but lower revenue than Health Catalyst. Duos Technologies Group is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Duos Technologies Group	$24.79M	14.26	-$9.84M	-$0.66	N/A
Health Catalyst	$302.48M	0.40	-$177.97M	-$3.72	N/A

In the previous week, Duos Technologies Group had 2 more articles in the media than Health Catalyst. MarketBeat recorded 4 mentions for Duos Technologies Group and 2 mentions for Health Catalyst. Duos Technologies Group's average media sentiment score of 0.53 beat Health Catalyst's score of 0.47 indicating that Duos Technologies Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Duos Technologies Group	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Health Catalyst	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

42.6% of Duos Technologies Group shares are owned by institutional investors. Comparatively, 85.0% of Health Catalyst shares are owned by institutional investors. 3.5% of Duos Technologies Group shares are owned by insiders. Comparatively, 19.4% of Health Catalyst shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Duos Technologies Group has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market. Comparatively, Health Catalyst has a beta of 1.66, meaning that its stock price is 66% more volatile than the broader market.

Summary

Health Catalyst beats Duos Technologies Group on 10 of the 16 factors compared between the two stocks.

How does Health Catalyst compare to Materialise?

Health Catalyst (NASDAQ:HCAT) and Materialise (NASDAQ:MTLS) are both small-cap computer software companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations.

Materialise has a net margin of 3.77% compared to Health Catalyst's net margin of -87.69%. Materialise's return on equity of 4.05% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-87.69%	-3.52%	-1.77%
Materialise	3.77%	4.05%	2.47%

Materialise has lower revenue, but higher earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than Materialise, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$302.48M	0.40	-$177.97M	-$3.72	N/A
Materialise	$267.53M	1.47	$8.73M	$0.20	33.25

Health Catalyst has a beta of 1.66, indicating that its share price is 66% more volatile than the broader market. Comparatively, Materialise has a beta of 1.33, indicating that its share price is 33% more volatile than the broader market.

In the previous week, Health Catalyst and Health Catalyst both had 2 articles in the media. Materialise's average media sentiment score of 1.78 beat Health Catalyst's score of 0.47 indicating that Materialise is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health Catalyst	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Materialise	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Health Catalyst currently has a consensus target price of $2.77, suggesting a potential upside of 69.07%. Materialise has a consensus target price of $10.00, suggesting a potential upside of 50.38%. Given Health Catalyst's higher probable upside, equities analysts clearly believe Health Catalyst is more favorable than Materialise.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.23
Materialise	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 19.3% of Materialise shares are held by institutional investors. 19.4% of Health Catalyst shares are held by company insiders. Comparatively, 1.2% of Materialise shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Materialise beats Health Catalyst on 9 of the 15 factors compared between the two stocks.

How does Health Catalyst compare to TruBridge?

TruBridge (NASDAQ:TBRG) and Health Catalyst (NASDAQ:HCAT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

TruBridge has a beta of 1.28, indicating that its stock price is 28% more volatile than the broader market. Comparatively, Health Catalyst has a beta of 1.66, indicating that its stock price is 66% more volatile than the broader market.

TruBridge has a net margin of 0.92% compared to Health Catalyst's net margin of -87.69%. TruBridge's return on equity of 18.75% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TruBridge	0.92%	18.75%	8.32%
Health Catalyst	-87.69%	-3.52%	-1.77%

TruBridge has higher revenue and earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than TruBridge, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TruBridge	$346.84M	1.13	$4.21M	$0.20	130.35
Health Catalyst	$302.48M	0.40	-$177.97M	-$3.72	N/A

In the previous week, TruBridge had 3 more articles in the media than Health Catalyst. MarketBeat recorded 5 mentions for TruBridge and 2 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 0.47 beat TruBridge's score of -0.01 indicating that Health Catalyst is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TruBridge	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Health Catalyst	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

TruBridge presently has a consensus target price of $23.95, indicating a potential downside of 8.13%. Health Catalyst has a consensus target price of $2.77, indicating a potential upside of 69.07%. Given Health Catalyst's stronger consensus rating and higher probable upside, analysts plainly believe Health Catalyst is more favorable than TruBridge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TruBridge	0 Sell rating(s)	8 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.23

88.6% of TruBridge shares are held by institutional investors. Comparatively, 85.0% of Health Catalyst shares are held by institutional investors. 10.7% of TruBridge shares are held by company insiders. Comparatively, 19.4% of Health Catalyst shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

TruBridge beats Health Catalyst on 10 of the 16 factors compared between the two stocks.

How does Health Catalyst compare to Xperi?

Xperi (NYSE:XPER) and Health Catalyst (NASDAQ:HCAT) are both small-cap computer software companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

94.3% of Xperi shares are held by institutional investors. Comparatively, 85.0% of Health Catalyst shares are held by institutional investors. 3.2% of Xperi shares are held by insiders. Comparatively, 19.4% of Health Catalyst shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Xperi has higher revenue and earnings than Health Catalyst. Xperi is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Xperi	$448.11M	0.81	-$56.34M	-$0.99	N/A
Health Catalyst	$302.48M	0.40	-$177.97M	-$3.72	N/A

Xperi presently has a consensus target price of $11.00, indicating a potential upside of 46.35%. Health Catalyst has a consensus target price of $2.77, indicating a potential upside of 69.07%. Given Health Catalyst's higher possible upside, analysts clearly believe Health Catalyst is more favorable than Xperi.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Xperi	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.23

Xperi has a net margin of -10.22% compared to Health Catalyst's net margin of -87.69%. Xperi's return on equity of 1.09% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Xperi	-10.22%	1.09%	0.73%
Health Catalyst	-87.69%	-3.52%	-1.77%

In the previous week, Health Catalyst had 1 more articles in the media than Xperi. MarketBeat recorded 2 mentions for Health Catalyst and 1 mentions for Xperi. Health Catalyst's average media sentiment score of 0.47 beat Xperi's score of 0.46 indicating that Health Catalyst is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Xperi	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Health Catalyst	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Xperi has a beta of 1.46, indicating that its stock price is 46% more volatile than the broader market. Comparatively, Health Catalyst has a beta of 1.66, indicating that its stock price is 66% more volatile than the broader market.

Summary

Xperi beats Health Catalyst on 9 of the 16 factors compared between the two stocks.

How does Health Catalyst compare to Similarweb?

Health Catalyst (NASDAQ:HCAT) and Similarweb (NYSE:SMWB) are both small-cap computer software companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, dividends, risk, valuation, earnings and institutional ownership.

In the previous week, Health Catalyst and Health Catalyst both had 2 articles in the media. Similarweb's average media sentiment score of 0.97 beat Health Catalyst's score of 0.47 indicating that Similarweb is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health Catalyst	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Similarweb	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 57.6% of Similarweb shares are held by institutional investors. 19.4% of Health Catalyst shares are held by insiders. Comparatively, 62.4% of Similarweb shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Similarweb has lower revenue, but higher earnings than Health Catalyst. Similarweb is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$302.48M	0.40	-$177.97M	-$3.72	N/A
Similarweb	$289.39M	1.28	-$32.94M	-$0.35	N/A

Health Catalyst has a beta of 1.66, indicating that its stock price is 66% more volatile than the broader market. Comparatively, Similarweb has a beta of 1.25, indicating that its stock price is 25% more volatile than the broader market.

Health Catalyst presently has a consensus target price of $2.77, suggesting a potential upside of 69.07%. Similarweb has a consensus target price of $7.07, suggesting a potential upside of 66.58%. Given Health Catalyst's stronger consensus rating and higher possible upside, analysts plainly believe Health Catalyst is more favorable than Similarweb.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.23
Similarweb	1 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18

Similarweb has a net margin of -10.38% compared to Health Catalyst's net margin of -87.69%. Health Catalyst's return on equity of -3.52% beat Similarweb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-87.69%	-3.52%	-1.77%
Similarweb	-10.38%	-48.57%	-4.45%

Summary

Health Catalyst beats Similarweb on 9 of the 15 factors compared between the two stocks.

Get Health Catalyst News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HCAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HCAT vs. The Competition

Export

Metric	Health Catalyst	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$121.19M	$1.53B	$6.51B	$11.99B
Dividend Yield	N/A	N/A	2.67%	5.62%
P/E Ratio	-0.44	77.53	24.24	24.13
Price / Sales	0.40	6.63	473.68	84.94
Price / Cash	0.80	23.11	43.05	54.72
Price / Book	0.47	4.88	10.49	6.82
Net Income	-$177.97M	-$54.76M	$3.56B	$337.52M
7 Day Performance	-15.46%	-6.93%	-2.02%	-0.96%
1 Month Performance	18.84%	2.59%	0.66%	1.68%
1 Year Performance	-58.59%	-9.89%	21.85%	26.88%

Health Catalyst Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HCAT Health Catalyst	3.6011 of 5 stars	$1.64 +2.5%	$2.77 +69.1%	-61.4%	$121.19M	$302.48M	N/A	1,200	High Trading Volume
DUOT Duos Technologies Group	3.138 of 5 stars	$14.24 +5.5%	$17.00 +19.4%	+41.5%	$395.86M	$24.79M	N/A	70	Gap Down
MTLS Materialise	2.9204 of 5 stars	$6.92 +3.8%	$10.00 +44.4%	+13.1%	$393.98M	$267.53M	34.23	2,556	Positive News High Trading Volume
TBRG TruBridge	2.3603 of 5 stars	$25.98 +0.1%	$23.95 -7.8%	+5.4%	$389.38M	$346.84M	129.80	3,500
XPER Xperi	3.5038 of 5 stars	$7.80 -1.9%	$11.00 +41.1%	N/A	$383.76M	$448.11M	N/A	1,460	News Coverage Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HCAT) was last updated on 6/11/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Health Catalyst (HCAT) Competitors

HCAT vs. DUOT, MTLS, TBRG, XPER, and SMWB

How does Health Catalyst compare to Duos Technologies Group?

Summary

How does Health Catalyst compare to Materialise?

Summary

How does Health Catalyst compare to TruBridge?

Summary

How does Health Catalyst compare to Xperi?

Summary

How does Health Catalyst compare to Similarweb?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HCAT vs. The Competition

Health Catalyst Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Health Catalyst (HCAT) Competitors

HCAT vs. DUOT, MTLS, TBRG, XPER, and SMWB

How does Health Catalyst compare to Duos Technologies Group?

Is DUOT or HCAT more profitable?

Do analysts recommend DUOT or HCAT?

Which has better earnings & valuation, DUOT or HCAT?

Does the media prefer DUOT or HCAT?

Do insiders & institutionals hold more shares of DUOT or HCAT?

Which has more volatility and risk, DUOT or HCAT?

Summary

How does Health Catalyst compare to Materialise?

Is HCAT or MTLS more profitable?

Which has stronger valuation & earnings, HCAT or MTLS?

Which has more volatility & risk, HCAT or MTLS?

Does the media refer more to HCAT or MTLS?

Do analysts recommend HCAT or MTLS?

Do insiders and institutionals have more ownership in HCAT or MTLS?

Summary

How does Health Catalyst compare to TruBridge?

Which has more volatility & risk, TBRG or HCAT?

Is TBRG or HCAT more profitable?

Which has preferable valuation and earnings, TBRG or HCAT?

Does the media prefer TBRG or HCAT?

Do analysts rate TBRG or HCAT?

Do insiders & institutionals believe in TBRG or HCAT?

Summary

How does Health Catalyst compare to Xperi?

Do insiders and institutionals believe in XPER or HCAT?

Which has preferable valuation and earnings, XPER or HCAT?

Do analysts rate XPER or HCAT?

Is XPER or HCAT more profitable?

Does the media favor XPER or HCAT?

Which has more risk and volatility, XPER or HCAT?

Summary

How does Health Catalyst compare to Similarweb?

Does the media refer more to HCAT or SMWB?

Do insiders & institutionals hold more shares of HCAT or SMWB?

Which has higher earnings and valuation, HCAT or SMWB?

Which has more risk and volatility, HCAT or SMWB?

Do analysts prefer HCAT or SMWB?

Is HCAT or SMWB more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HCAT vs. The Competition

Health Catalyst Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools